Title : Dipeptidyl peptidase IV inhibitors: a promising new therapeutic approach for the management of type 2 diabetes.

Pub. Date : 2006

PMID : 16242377






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In recent studies of 3-12 months duration in patients with type 2 diabetes, dipeptidyl peptidase IV inhibitors have proved efficacious, both as monotherapy and when given in combination with metformin. Metformin dipeptidyl peptidase 4 Homo sapiens